Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: NCT05685173 ×

NCT05685173

This institution is selected. Its supporting articles are shown below.

NCT056851731

Articles mentioning NCT05685173

1 articles · page 1 of 1

635 The impact of bispecific antibody CD22xCD28 on anti-tumor efficacy of odronextamab and T cell activation and function in B cell tumor models

jitc · abstract · 2025-11-04 · 1 matching annotations

75.2%

National Institutes of Health NCT05685173 Odronextamab non-Hodgkin lymphoma REGN5837 odronextamab-mediated DLBCL follicular lymphoma

…ith the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocols were approved by the Regeneron Pharmaceuticals I…

Browse institutions

NCT05685173

Articles mentioning NCT05685173

635 The impact of bispecific antibody CD22xCD28 on anti-tumor efficacy of odronextamab and T cell activation and function in B cell tumor models